Publication:
Virosome and ISCOM vaccines against Newcastle disease: Preparation, characterization and immunogenicity

dc.contributor.authorAtthachai Homhuanen_US
dc.contributor.authorSompol Prakongpanen_US
dc.contributor.authorPrachak Poomvisesen_US
dc.contributor.authorRiks A. Maasen_US
dc.contributor.authorDaan J.A. Crommelinen_US
dc.contributor.authorGideon F.A. Kerstenen_US
dc.contributor.authorWim Jiskooten_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherChulalongkorn Universityen_US
dc.contributor.otherWageningen University and Research Centreen_US
dc.contributor.otherUtrecht Institute of Pharmaceutical Sciencesen_US
dc.contributor.otherNetherlands Vaccine Institute - NVIen_US
dc.date.accessioned2018-07-24T03:56:51Z
dc.date.available2018-07-24T03:56:51Z
dc.date.issued2004-08-01en_US
dc.description.abstractThe purpose of this study was to prepare and characterize virosomes and ISCOMs containing envelope proteins of Newcastle disease virus (NDV) and to evaluate their immunogenicity in target animals (chickens). Virosomes were prepared by solubilization of virus with either Triton X-100 or octyl glucoside (OG) followed by detergent removal. Biochemical analysis revealed that these virosomes contained both the haemagglutinin-neuraminidase protein (HN) and the fusion protein (F), with preserved biological activity. Acidic environment triggered the fusion between virosomes and chicken erythrocyte ghosts. Formation of ISCOMs was achieved by solubilizing phospholipids, cholesterol, envelope protein antigen and Quil A in Triton X-100. The ISCOM particles were formed by removal of the detergent. In each formulation the relative HN content correlated with the capability to agglutinate red blood cells. The immunogenicity of these lipid-based subunit vaccines was determined in chickens after subcutaneous immunization. The relative HN content of the subunit vaccines correlated with the haemagglutination-inhibition (HI) antibody titres. Virosomes prepared with Triton X-100 and ISCOMs offered high clinical protection (> 80%) upon challenge with virulent NDV. Virosomes prepared with OG yielded lower clinical protection despite high HI antibody titres. Virosomes with reduced antigen density showed poor immunogenicity and protection. In conclusion, ND virosomes and ISCOMs were found to be immunogenic and provided good protection. © 2004 Elsevier B.V. All rights reserved.en_US
dc.identifier.citationEuropean Journal of Pharmaceutical Sciences. Vol.22, No.5 (2004), 459-468en_US
dc.identifier.doi10.1016/j.ejps.2004.05.005en_US
dc.identifier.issn09280987en_US
dc.identifier.other2-s2.0-3242703841en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/21800
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=3242703841&origin=inwarden_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleVirosome and ISCOM vaccines against Newcastle disease: Preparation, characterization and immunogenicityen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=3242703841&origin=inwarden_US

Files

Collections